找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Advances in Rapid Sex-Steroid Action; New Challenges and N Gabriella Castoria,Antimo Migliaccio Book 2012 Springer Science+Business Media,

[復(fù)制鏈接]
查看: 8689|回復(fù): 56
樓主
發(fā)表于 2025-3-21 19:38:18 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
期刊全稱Advances in Rapid Sex-Steroid Action
期刊簡稱New Challenges and N
影響因子2023Gabriella Castoria,Antimo Migliaccio
視頻videohttp://file.papertrans.cn/150/149543/149543.mp4
發(fā)行地址This volume provides an up-to-date review of recently discovered rapid action of sex steroid hormones.Recent years have seen the discovery of significant numbers of master proteins in breast and prost
圖書封面Titlebook: Advances in Rapid Sex-Steroid Action; New Challenges and N Gabriella Castoria,Antimo Migliaccio Book 2012 Springer Science+Business Media,
影響因子Breast and prostate cancers are both hormone-dependent, at least in some stages of their progression. Hormonal manipulation represents an important therapeutic approach. Although most of breast and prostate cancers initially respond to hormone therapy, most tumors reinitiate to growth. Finally, hormone-resistant and metastatic breast and prostate cancers may develop. Thus, the challenge is the dissection of mechanisms by which steroid receptor signaling pathways continue to influence cell growth and invasiveness. Compelling evidence indicates that steroid hormones elicit non-genomic responses in extra-nuclear compartment of target cells. In this cellular location, steroid-coupled receptors rapidly recruit signaling effectors or scaffold proteins and activate multiple pathways leading to proliferation, survival, migration and invasiveness. The immediate challenge is the dissection of key events regulating the steroid response of target tissues to prevent progression and improve treatment of breast and prostate cancers.
Pindex Book 2012
The information of publication is updating

書目名稱Advances in Rapid Sex-Steroid Action影響因子(影響力)




書目名稱Advances in Rapid Sex-Steroid Action影響因子(影響力)學(xué)科排名




書目名稱Advances in Rapid Sex-Steroid Action網(wǎng)絡(luò)公開度




書目名稱Advances in Rapid Sex-Steroid Action網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Advances in Rapid Sex-Steroid Action被引頻次




書目名稱Advances in Rapid Sex-Steroid Action被引頻次學(xué)科排名




書目名稱Advances in Rapid Sex-Steroid Action年度引用




書目名稱Advances in Rapid Sex-Steroid Action年度引用學(xué)科排名




書目名稱Advances in Rapid Sex-Steroid Action讀者反饋




書目名稱Advances in Rapid Sex-Steroid Action讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:24:12 | 只看該作者
板凳
發(fā)表于 2025-3-22 03:00:44 | 只看該作者
f significant numbers of master proteins in breast and prostBreast and prostate cancers are both hormone-dependent, at least in some stages of their progression. Hormonal manipulation represents an important therapeutic approach. Although most of breast and prostate cancers initially respond to horm
地板
發(fā)表于 2025-3-22 04:42:04 | 只看該作者
S. G. Ponnambalam,N. Jawahar,B. S. Girish for the treatment of breast cancer, as well as other malignancies. Several small-molecule inhibitors and monoclonal antibodies are currently being tested or used in the clinic for the treatment of these tumors.
5#
發(fā)表于 2025-3-22 11:51:57 | 只看該作者
6#
發(fā)表于 2025-3-22 13:30:50 | 只看該作者
7#
發(fā)表于 2025-3-22 20:02:05 | 只看該作者
8#
發(fā)表于 2025-3-22 22:23:50 | 只看該作者
9#
發(fā)表于 2025-3-23 01:30:15 | 只看該作者
Nongenomic Actions of Estrogens and Xenoestrogens Affecting Endocrine Cancer Cellsreceptors and signaling systems, but do so imperfectly, causing disruptions to both the phasing and dose-responsiveness of physiologic estrogens. Disruptions to the signaling of different physiologic estrogens could cause life stage-specific tissue malfunctions or cancer vulnerabilities.
10#
發(fā)表于 2025-3-23 06:59:01 | 只看該作者
Androgen Receptor Pathway in Prostate Cancer: Old Target and New Drugsement. Several novel agents targeting the androgen receptor signaling are currently being evaluated including Abiraterone, MDV-3100, orteronel (TAK-700), and other compounds currently in early development.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 05:20
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
宾川县| 聂荣县| 缙云县| 咸丰县| 积石山| 祁连县| 安吉县| 大新县| 徐州市| 汉中市| 牡丹江市| 宜宾县| 大同县| 梨树县| 会东县| 渭源县| 浦城县| 湘潭市| 大理市| 尉犁县| 明星| 内丘县| 苗栗市| 稷山县| 庄浪县| 莱芜市| 当雄县| 武穴市| 荥阳市| 林州市| 隆回县| 赤壁市| 通州区| 永和县| 敦煌市| 桐柏县| 丰台区| 临沧市| 团风县| 长乐市| 任丘市|